New Therapeutics in Alzheimer's Disease Longitudinal Cohort study (NTAD): study protocol.

Juliette Helene Lanskey Ece Kocagoncu Andrew J QuinnYun-Ju ChengMelek KaradagJemma PittStephen LoweMichael PerkintonVanessa Raymont Krish D Singh Mark W Woolrich Anna Christina Nobre Richard N A Henson James Benedict Rowenull null

Published in: BMJ open (2022)

The study has received a favourable opinion from the East of England Cambridge Central Research Ethics Committee (REC reference 18/EE/0042). Results will be disseminated through internal reports, peer-reviewed scientific journals, conference presentations, website publication, submission to regulatory authorities and other publications. Data will be made available via the Dementias Platform UK Data Portal on completion of initial analyses by the NTAD study group.

Keyphrases

study protocol
big data
randomized controlled trial
electronic health record
small molecule
clinical trial
public health
emergency department
cross sectional
transcription factor
deep learning
artificial intelligence
single cell
adverse drug